rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-11-26
|
pubmed:abstractText |
Cutaneous manifestations occur frequently in inflammatory bowel disease. The association between hidradenitis suppurativa (HS) and Crohn's disease (CD) has been reported. We present a new case supporting this association. A dramatic improvement after treatment with infliximab was achieved for both refractory fistulizing CD and axillary HS.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1078-0998
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
323-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11720323-Adult,
pubmed-meshheading:11720323-Antibodies, Monoclonal,
pubmed-meshheading:11720323-Axilla,
pubmed-meshheading:11720323-Crohn Disease,
pubmed-meshheading:11720323-Drug Eruptions,
pubmed-meshheading:11720323-Female,
pubmed-meshheading:11720323-Gastrointestinal Agents,
pubmed-meshheading:11720323-Hidradenitis Suppurativa,
pubmed-meshheading:11720323-Humans,
pubmed-meshheading:11720323-Rectovaginal Fistula,
pubmed-meshheading:11720323-Tumor Necrosis Factor-alpha
|
pubmed:year |
2001
|
pubmed:articleTitle |
Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
|
pubmed:affiliation |
Department of Gastroenterology and Hepatology, Hospital La Fe, Valencia, Spain. Fernandomarju@hotmail.com
|
pubmed:publicationType |
Journal Article,
Case Reports
|